首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay.
Authors:J A C Schalk  C G J C A de Vries  P M J M Jongen
Institution:National Institute for Public Health and the Environment, Centre for Biological Medicines and Medical Technology, Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands. marjolijn.schalk@rivm.nl
Abstract:The quantitative PCR infectivity assay is a combination of virus propagation and quantitative PCR. Previously Schalk JAC, van den Elzen C, Ovelgonne H, Baas C, Jongen PMJM. Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR. J Virol Methods 2004;117:179-87.], we used this assay to estimate the titer of infectious measles virus in trivalent, live, measles, mumps, rubella vaccines (MMR). Here we describe the further improvement and development of the assay for simultaneous potency estimation of measles, mumps and rubella viruses. The potency of measles and mumps virus is estimated within one assay after 1 day of cell culture. The potency of rubella virus is estimated in a separate assay after 2 days of cell culture. Compared to conventional CCID50 and plaque assays, the quantitative PCR infectivity assay has the advantage in being fast because the assay is not dependent on the formation of cytopathic effect. Furthermore assay design is simplified: serological neutralization can be omitted because PCR is virus-specific and, under the conditions used, the individual components of trivalent measles, mumps, rubella vaccines do not interfere with each other. The assay was validated and compared to the performance of a plaque assay.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号